(0.20%) 5 142.00 points
(0.20%) 38 518 points
(0.26%) 17 893 points
(-0.95%) $83.05
(1.61%) $1.954
(-0.14%) $2 344.00
(0.08%) $27.56
(0.64%) $928.00
(-0.21%) $0.933
(-0.25%) $11.00
(-0.28%) $0.798
(1.13%) $92.91
0.99% HKD 5.09
Live Chart Being Loaded With Signals
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong...
Stats | |
---|---|
Dzisiejszy wolumen | 11.35M |
Średni wolumen | 9.19M |
Kapitalizacja rynkowa | 31.98B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.160 ( 2023-06-05 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.71 |
ATR14 | HKD0.00400 (0.08%) |
Wolumen Korelacja
China Resources Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
China Resources Korelacja - Waluta/Towar
China Resources Finanse
Annual | 2023 |
Przychody: | HKD270.40B |
Zysk brutto: | HKD42.36B (15.67 %) |
EPS: | HKD0.680 |
FY | 2023 |
Przychody: | HKD270.40B |
Zysk brutto: | HKD42.36B (15.67 %) |
EPS: | HKD0.680 |
FY | 2022 |
Przychody: | HKD254.11B |
Zysk brutto: | HKD39.13B (15.40 %) |
EPS: | HKD0.660 |
FY | 2021 |
Przychody: | HKD236.81B |
Zysk brutto: | HKD35.38B (14.94 %) |
EPS: | HKD0.600 |
Financial Reports:
No articles found.
China Resources Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.160 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0900 | 2017-05-24 |
Last Dividend | HKD0.160 | 2023-06-05 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | HKD0.980 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.48 | -- |
Div. Sustainability Score | 8.46 | |
Div.Growth Potential Score | 4.24 | |
Div. Directional Score | 6.35 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2314.HK | Ex Dividend Junior | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
1283.HK | Ex Dividend Junior | 2023-09-22 | Semi-Annually | 0 | 0.00% | |
0341.HK | Ex Dividend Junior | 2023-09-12 | Annually | 0 | 0.00% | |
6083.HK | Ex Dividend Knight | 2023-06-12 | Semi-Annually | 0 | 0.00% | |
1843.HK | Ex Dividend Knight | 2023-09-05 | Annually | 0 | 0.00% | |
0868.HK | Ex Dividend Knight | 2023-08-11 | Semi-Annually | 0 | 0.00% | |
0016.HK | Ex Dividend Knight | 2023-11-06 | Semi-Annually | 0 | 0.00% | |
2633.HK | Ex Dividend Knight | 2023-08-15 | Semi-Annually | 0 | 0.00% | |
1412.HK | Ex Dividend Knight | 2023-06-12 | Semi-Annually | 0 | 0.00% | |
0497.HK | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0158 | 1.500 | 9.68 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0156 | 1.200 | 9.48 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0800 | 1.500 | -0.222 | -0.334 | [0.1 - 1] |
payoutRatioTTM | 0.245 | -1.000 | 7.55 | -7.55 | [0 - 1] |
currentRatioTTM | 1.330 | 0.800 | 8.35 | 6.68 | [1 - 3] |
quickRatioTTM | 0.799 | 0.800 | -0.00494 | -0.00395 | [0.8 - 2.5] |
cashRatioTTM | 0.236 | 1.500 | 9.80 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.313 | -1.500 | 4.79 | -7.19 | [0 - 0.6] |
interestCoverageTTM | 4.41 | 1.000 | 9.48 | 9.48 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.555 | 2.00 | 9.48 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.054 | 2.00 | 9.47 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.678 | -1.500 | 3.29 | -4.93 | [0 - 2.5] |
grossProfitMarginTTM | 0.157 | 1.000 | -0.722 | -0.722 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0431 | 1.000 | -1.139 | -1.139 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.127 | 1.000 | -0.407 | -0.407 | [0.2 - 2] |
assetTurnoverTTM | 0.992 | 0.800 | 6.72 | 5.38 | [0.5 - 2] |
Total Score | 8.46 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.38 | 1.000 | 9.25 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0800 | 2.50 | -0.143 | -0.334 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.054 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.11 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.555 | 2.00 | 9.48 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.245 | 1.500 | 7.55 | -7.55 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0399 | 1.000 | -1.502 | 0 | [0.1 - 0.5] |
Total Score | 4.24 |
China Resources
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. The company also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it is involved in property holding activities. As of December 31, 2021, the company operated 801 retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej